Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
We examined the optimal timing for the enhancement of antitumor effects of CDDP analogues, cis- diammine-1,1- cyclobutane dicarboxylate platinum (II); CBDCA combined with hyperthermia against the CD-1 mice bearing Ehrlich ascites tumor (EAT) cells in vivo. The prolonged tumor doubling time was observed when two modalities were combined. The longest tumor doubling time was obtained by simultaneous administration of CBDCA combined with hyperthermia. The findings indicated that the most effective condition was the simultaneous combination of CBDCA with hyperthermia. An increase in intratumoral platinum concentration was observed by the treatment of CBDCA simultaneous combined with hyperthermia.
Mizuuchi
H
H
Department of Oral and Maxillofacial Surgery 1, Hiroshima University School of Dentistry, Japan.
Yoshiga
K
K
Sakurai
K
K
Tsumura
M
M
Takada
K
K
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D016190:Carboplatin / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D006979:Hyperthermia, Induced; D051379:Mice; D008815:Mice, Inbred Strains; D010984:Platinum / Q000097:blood
D000970:Antineoplastic Agents; D010984:Platinum; D016190:Carboplatin